Teiko Komori Nomura, Satoshi Endo, Takuma Kuwano, Kazuya Fukasawa, Shigeo Takashima, Tomoki Todo, Kyoji Furuta, Takuhei Yamamoto, Eiichi Hinoi, Hiroko Koyama, et al. ARL-17477 is a dual inhibitor of NOS1 and the autophagic-lysosomal system that prevents tumor growth in vitro and in vivo. Scientific reports. 2023. 13. 1. 10757-10757
Gyujin Park, Kazuya Fukasawa, Tetsuhiro Horie, Yusuke Masuo, Yuka Inaba, Takanori Tatsuno, Takanori Yamada, Kazuya Tokumura, Sayuki Iwahashi, Takashi Iezaki, et al. L-type amino acid transporter 1 in hypothalamic neurons in mice maintains energy and bone homeostasis. JCI insight. 2023
Kazuya Fukasawa, Jiajun Lyu, Takuya Kubo, Yuki Tanaka, Akane Suzuki, Tetsuhiro Horie, Akane Tomizawa, Ryoma Osumi, Sayuki Iwahashi, Kazuya Tokumura, et al. MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells. Cancer Research Communications. 2023. 3. 1. 148-159
Makoto Yoshimoto, Koki Sadamori, Kazuya Tokumura, Yuki Tanaka, Kazuya Fukasawa, Eiichi Hinoi. Bioinformatic analysis reveals potential relationship between chondrocyte senescence and protein glycosylation in osteoarthritis pathogenesis. Frontiers in endocrinology. 2023. 14. 1153689-1153689
Jiajun Lyu, Takuya Kubo, Sayuki Iwahashi, Kazuya Fukasawa, Tetsuhiro Horie, Katashi Nagamatsu, Kumiko Ikeno, Genjiro Nakamura, Masaki Kamakura, Eiichi Hinoi. Amelioration of Osteoarthritis Development by Daily Oral Supplementation of Royal Jelly. Biological & pharmaceutical bulletin. 2023. 46. 2. 348-353
深澤和也, PARK Gyujin, 檜井栄一. L-type amino acid transporter 1 in hypothalamic neurons controls energy and bone homeostasis. 日本薬学会年会要旨集(Web). 2022. 142nd
岩橋咲幸, 門田卓也, 深澤和也, 家崎高志, 白波瀬弘明, 北尾達哉, 檜井栄一. Therapeutic inhibition of CDK8 on abnormal bone development in Achondroplasia model mice. 日本薬学会年会要旨集(Web). 2022. 142nd
岡山靖佳, 落合信介, 堀江哲寛, 家崎高志, 深澤和也, 鎌倉昌樹, 池野久美子, 永松剛, 檜井栄一. Daily oral intake of Royal Jelly prevents cartilage degeneration in osteoarthritis model mice. 日本薬学会年会要旨集(Web). 2022. 142nd
鈴木紅音, 深澤和也, 堀江哲寛, 村田美怜, 小林正輝, 檜井栄一. ERK5 controls stemness and tumorigenicity of glioma stem cells by regulating the STAT3 signaling. 日本薬学会年会要旨集(Web). 2022. 142nd
深澤和也, 徳村和也, 岩橋咲幸, 家崎高志, 檜井栄一. CDK8/c-MYC axis as a novel therapeutic target for glioblastoma. 日本薬学会年会要旨集(Web). 2021. 141st
- 2003 Kanazawa University Division of natural sciences
1998 - 2000 Setsunan University Graduate School of Pharmaceutical Sciences
- 2000 Setsunan University Division of Parmaceutical Sciences
1994 - 1998 Setsunan University Faculty of Pharmaceutical Sciences
- 1998 Setsunan University Faculty of Pharmaceutical Sciences
Show all
Professional career (1)：
博士(薬学) (金沢大学)
Work history (13)：
2023/01 - 現在 Gifu University
2021/11 - 現在 JST次世代研究者挑戦的研究プログラム(SPRING)事業統括
2019/10 - 現在 岐阜大学大学院連合創薬医療情報研究科教授(兼務)
2019/07 - 現在 Gifu Pharmaceutical University Faculty of Pharmaceutical Science
2009/05 - 2019/06 Kanazawa University Institute of Medical, Pharmaceutical and Health Sciences
2006/07 - 2009/04 Columbia University
2006/04 - 2007/12 日本学術振興会海外特別研究員
2006/04 - 2006/06 ベイラー医科大学分子遺伝学部門博士研究員
2004/04 - 2006/03 Kanazawa University Graduate School of Natural Science and Technology
2003/04 - 2004/03 Kanazawa University Faculty of Pharmaceutical Sciences
2001/04 - 2003/03 日本学術振興会特別研究員DC2
2002/07 - 2002/12 Harvard University
1998/07 - 1998/08 チェコ国立科学アカデミー生理学研究所生理学部門研究員
Show all
Awards (5)：
2014 - 平成26年度長寿科学振興財団長寿科学賞
2012 - 平成24年度日本薬学会奨励賞
2012 - 第27回日本薬理学会学術奨励賞
2010 - ノボノルディスク成長発達研究賞2010
2009 - 平成21年度日本薬学会北陸支部学術奨励賞
Association Membership(s) (4)：
THE JAPANESE SOCIETY FOR REGENERATIVE MEDICINE
, JAPANESE SOCIETY FOR BONE AND MINERAL RESEARCH
, THE JAPANESE PHARMACOLOGICAL SOCIETY
, THE PHARMACEUTICAL SOCIETY OF JAPAN
